NASDAQ

Janux Therapeutics, Inc. (JANX)

♥ 599 Thanks from members

Live price chart, market sentiment, and community perspectives for Janux Therapeutics, Inc. (NASDAQ: JANX).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: Health CareIndustry: BiotechnologyFounder: J. Christopher LoveFounder: Shom GoelLeadership: David Meek (CEO)Leadership: Shom Goel (CSO)Holder: VenrockHolder: Redmile GroupHolder: RA Capital ManagementTRACTr TechnologyANXT201Tumor-Activated T Cell Engagers#JANX#Janux Therapeutics#Biotech stock#T-cell engagers#NASDAQ JANX